Use of mycophenolate mofetil in children with chronic, refractory immune cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS).

被引：0
|
作者：
Rao, VK [1 ]
Dale, J [1 ]
Hurley, J [1 ]
Dugan, F [1 ]
Tretler, J [1 ]
Straus, SE [1 ]
机构：
[1] NIAID, Clin Invest Lab, NIH, Bethesda, MD 20892 USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1015
引用
收藏
页码：285A / 285A
页数：1
相关论文
共 50 条
  • [1] USE OF MYCOPHENOLATE MOFETIL IN CHILDREN WITH CHRONIC, REFRACTORY IMMUNE CYTOPENIAS ASSOCIATED WITH AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME (ALPS)
    Rao, V. Koneti
    Price, Susan
    Perkins, Katie
    Aldridge, Patricia
    Treller, Jean
    Davis, Joie
    Dowdell, Kennichi
    Niemela, Julie
    Brown, Margaret
    Fleisher, Thomas
    PEDIATRIC BLOOD & CANCER, 2009, 52 (06) : 697 - 697
  • [2] Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome
    Rao, VK
    Dugan, F
    Dale, JK
    Davis, J
    Tretler, J
    Hurley, JK
    Fleisher, T
    Puck, J
    Straus, SE
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (04) : 534 - 538
  • [3] Use of rituximab for refractory immune cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS)
    Dale, Janet K.
    Price, Susan
    Tretler, Jean
    Aldridge, Patricia
    Montague, Stephanie
    Davis, Joie
    Gill, Fred
    Hartman, Kip R.
    Stork, Linda C.
    Gnarra, David J.
    Krishnamurti, Lakshmianan
    Puck, Jennifer
    Fleisher, Thomas
    Rao, V. Koneti
    BLOOD, 2007, 110 (11) : 397A - 397A
  • [4] Use of Rituximab for Refractory Cytopenias Associated With Autoimmune Lymphoproliferative Syndrome (ALPS)
    Rao, V. Koneti
    Price, Susan
    Perkins, Katie
    Aldridge, Patricia
    Tretler, Jean
    Davis, Joie
    Dale, Janet K.
    Gill, Fred
    Hartman, Kip R.
    Stork, Linda C.
    Gnarra, David J.
    Krishnamurti, Lakshmanan
    Newburger, Peter E.
    Puck, Jennifer
    Fleisher, Thomas
    PEDIATRIC BLOOD & CANCER, 2009, 52 (07) : 847 - 852
  • [5] Mycophenolate Mofetil Treatment in Children with Autoimmune Lymphoproliferative Syndrome
    Albayrak, D.
    Albayrak, C.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S176 - S177
  • [6] FREQUENCY OF AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME IN CHILDREN WITH CHRONIC IMMUNE CYTOPENIAS AND NEWLY DIAGNOSED LYMPHOMA
    Kaya, Z.
    Isik, M.
    Bagriacik, E. U.
    Pinarli, F. G.
    Kocak, U.
    Yenicesu, I.
    Gursel, T.
    HAEMATOLOGICA, 2015, 100 : 557 - 557
  • [7] Autoimmune Cytopenias in Nonmalignant Lymphoproliferative Disorders: Thinking Beyond ALPS(Autoimmune Lymphoproliferative Syndrome)
    Kulm, Elaine
    Webster, Sharon
    Howe, Kate
    Rump, Amy
    Uzel, Gulbu
    Rao, V. Koneti
    BLOOD, 2020, 136
  • [8] Mycophenolate mofetil as an alternate immunosuppressor for autoimmune lymphoproliferative syndrome
    Kossiva, Lydia
    Theodoridou, Maria
    Mostrou, Glykeria
    Vrachnou, Effie
    Le Deist, Francoise
    Rieux-Laucat, Frederick
    Kanariou, Maria G.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2006, 28 (12) : 824 - 826
  • [9] Mycophenolate Mofetil and Thrombopoietin Receptor Agonists in the Treatment of Refractory Thrombocytopenia in Patients with Autoimmune Lymphoproliferative Syndrome
    Chang, Leejah
    Price, Susan
    Perkins, Katie
    Davis, Joie
    Aldridge, Patricia
    Recht, Michael
    Kelleher, John
    Rao, V. Koneti
    BLOOD, 2011, 118 (21) : 965 - 966
  • [10] Autoimmune lymphoproliferative syndrome (ALPS) in children
    Resnick, I
    Kondratenko, I
    Molotkovskaya, I
    Konopleva, E
    Reznikov, Y
    Baydun, L
    Poverenny, A
    Rieux-Laucat, F
    Le Deist, F
    IX MEETING OF THE EUROPEAN SOCIETY FOR IMMUNODEFICIENCIES, 2000, : 197 - 205
12345